Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy?
使用二肽基肽酶-4抑制劑調節巨噬細胞:治療糖尿病性心肌病的新前沿?
World J Diabetes 2024-09-16
Impact of baseline characteristics on the efficacy of once-weekly subcutaneous semaglutide among participants with type 2 diabetes: A post hoc analysis of SUSTAIN China.
基線特徵對於參與者使用每週一次皮下注射 semaglutide 治療 2 型糖尿病的療效影響:SUSTAIN China 的事後分析。
Diabetes Obes Metab 2024-09-16
Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants.
Cagrilintide 與臨床相關的 QTc 延長無關:在健康參與者中的徹底 QT 研究。
Diabetes Obes Metab 2024-09-16
The impact of glucagon and exenatide on oxidative stress levels and antioxidative enzyme expression in in vitro induced steatosis in HepG2 cell culture.
胰高血糖素和exenatide對HepG2細胞培養中誘導的脂肪變性氧化壓力水平及抗氧化酶表達的影響。
Endokrynol Pol 2024-09-16
Megesterol acetate as an overlooked cause of hyperglycemia in end-stage renal disease: A case of polypharmacy.
Megesterol acetate 作為末期腎病中被忽視的高血糖原因:一例多重用藥的案例。
J Am Pharm Assoc (2003) 2024-09-14